Revolution is developing drugs that target a molecular driver of cancers.
Source link
Merck in Talks to Buy Revolution Medicines for Around $30 Billion
Date:
More like thisRelated
United Approached Delta Last Year About Merging Airlines
United Chief Executive Scott Kirby called Delta’s CEO to...
Ranking every FIFA World Cup from 1930 to 2026
Bill ConnellyCloseBill ConnellyESPN Staff WriterBill Connelly is a writer...
First Kenyan-born NFL player deported, ICE says
A former Indianapolis Colts linebacker from Kenya was deported...
GLP-1 drugs could reduce long-term sick leave: Study
Based on Danish data, the study found those on...